Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FKD25
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,249
Award facts
- Contract value 100% obligated
- $20,249.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,249.19 to AmerisourceBergen Drug Corp for the supply of CIMZIA 2x200 mg/ml syringe kits, with an ultimate completion date of September 29, 2025. This is a firm fixed-price delivery order awarded competitively with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. CIMZIA (certolizumab pegol) is a biologic immunosuppressant used to treat inflammatory conditions including rheumatoid arthritis and Crohn's disease. This delivery order represents a specific requisition for specialty pharmaceutical products to support military medical supply chain requirements. AmerisourceBergen's substantial contract portfolio with the Defense Logistics Agency demonstrates its established capability as a critical vendor for federal medical procurement, supplying medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FKD25?
SPE2DB25FKD25 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FKD25 worth?
The government has obligated $20,249 on SPE2DB25FKD25.
Is contract SPE2DB25FKD25 an order under another contract?
Yes. SPE2DB25FKD25 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKD25 competed?
The extent of competition for SPE2DB25FKD25 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award